BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19339882)

  • 1. Recent advances in the management of intestinal failure-associated liver disease.
    Wiles A; Woodward JM
    Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):265-72. PubMed ID: 19339882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.
    Venick RS; Calkins K
    Curr Opin Organ Transplant; 2011 Jun; 16(3):306-11. PubMed ID: 21505340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention and treatment of intestinal failure-associated liver disease in neonates and children.
    Nehra D; Fallon EM; Puder M
    Surg Clin North Am; 2011 Jun; 91(3):543-63. PubMed ID: 21621695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 lipids for intestinal failure associated liver disease.
    Diamond IR; Pencharz PB; Wales PW
    Semin Pediatr Surg; 2009 Nov; 18(4):239-45. PubMed ID: 19782305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
    Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
    Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future.
    Carter BA; Karpen SJ
    Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
    Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis.
    Diamond IR; de Silva NT; Tomlinson GA; Pencharz PB; Feldman BM; Moore AM; Ling SC; Wales PW
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5):596-602. PubMed ID: 21825088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of magnetic resonance spectroscopy of the liver in patients receiving long-term parenteral nutrition.
    Woodward JM; Priest AN; Hollingsworth KG; Lomas DJ
    JPEN J Parenter Enteral Nutr; 2009; 33(6):669-76. PubMed ID: 19587386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Failure-Associated Liver Disease in Neonates.
    Fundora J; Aucott SW
    Neoreviews; 2020 Sep; 21(9):e591-e599. PubMed ID: 32873652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric intestinal failure-associated liver disease.
    Courtney CM; Warner BW
    Curr Opin Pediatr; 2017 Jun; 29(3):363-370. PubMed ID: 28333693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children.
    Norsa L; Nicastro E; Di Giorgio A; Lacaille F; D'Antiga L
    Nutrients; 2018 May; 10(6):. PubMed ID: 29882922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish oil emulsions in the management of intestinal failure-associated liver disease.
    Mercer DF
    J Clin Gastroenterol; 2012; 46(10):823-7. PubMed ID: 23060217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal failure-associated liver disease: what do we know today?
    Kelly DA
    Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights Into Intestinal Failure-Associated Liver Disease in Children.
    Khalaf RT; Sokol RJ
    Hepatology; 2020 Apr; 71(4):1486-1498. PubMed ID: 32003009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal failure-associated liver disease in the neonatal ICU: what we know and where we're going.
    Khalaf RT; Ford SL
    Curr Opin Pediatr; 2022 Apr; 34(2):184-190. PubMed ID: 35051980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.
    Lauriti G; Zani A; Aufieri R; Cananzi M; Chiesa PL; Eaton S; Pierro A
    JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):70-85. PubMed ID: 23894170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional management of infants with short bowel syndrome.
    Wessel JJ; Kocoshis SA
    Semin Perinatol; 2007 Apr; 31(2):104-11. PubMed ID: 17462495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal failure-associated liver disease in hospitalised children.
    Pichler J; Horn V; Macdonald S; Hill S
    Arch Dis Child; 2012 Mar; 97(3):211-4. PubMed ID: 22247247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.